Cite
[Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
MLA
Boutitie, F., et al. “[Monitoring of Clinical Trials and Interim Analysis. 1. Monitoring Committee].” Therapie, vol. 47, no. 4, July 1992, pp. 345–49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1494799&authtype=sso&custid=ns315887.
APA
Boutitie, F., Bellissant, E., Blanchard, J., Boissel, J. P., Cauquil, J., Chauvin, F., Derzko, G., Ducruet, T., Durrleman, S., Girre, J. P., & et. al. (1992). [Monitoring of clinical trials and interim analysis. 1. Monitoring committee]. Therapie, 47(4), 345–349.
Chicago
Boutitie, F, E Bellissant, J Blanchard, J P Boissel, J Cauquil, F Chauvin, G Derzko, et al. 1992. “[Monitoring of Clinical Trials and Interim Analysis. 1. Monitoring Committee].” Therapie 47 (4): 345–49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1494799&authtype=sso&custid=ns315887.